Mydecine Innovations Group
About:
Mydecine Innovations Group is a biotechnology company that develops a novel therapeutics to treat mental health and addiction disorders.
Website: https://mydecineinc.com/
Description:
Mydecine Innovations Group is a biotechnology company that develops a novel therapeutics to treat mental health and addiction disorders. They use a world-class technology and drug development infrastructure, and advances new treatment options in areas of significant unmet need. Founded in 2020, the company is based in Vancouver, British Columbia, Canada.
Total Funding Amount:
$7.55M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Vancouver, British Columbia, Canada
Founded Date:
2013-09-27
Contact Email:
info(AT)mydecineinc.com
Founders:
Number of Employees:
11-50
Last Funding Date:
2023-09-15
IPO Status:
Public
Industries:
© 2025 bioDAO.ai